5 Key Takeaways

• 1

  Effective communication about glaucoma stages and treatments is crucial for optimal patient outcomes.

• 2

  Topical eye drops, while perceived as benign, can significantly decrease quality of life due to side effects and compliance issues.

• 3

  Patients often expect oral medications before considering other interventions, complicating treatment approaches.

• 4

  New interventions like MIGS and sustained delivery can replace topical therapy and may be superior in early disease stages.

• 5

  Emphasizing the downsides of long-term topical therapy and tailoring discussions about glaucoma can improve patient acceptance of treatments.